Cargando…

Comparing methods to predict baseline mortality for excess mortality calculations

BACKGROUND: The World Health Organization (WHO)’s excess mortality estimates presented in May 2022 stirred controversy, due in part to the high estimate provided for Germany, which was later attributed to the spline model used. This paper aims to reproduce the problem using synthetic datasets, thus...

Descripción completa

Detalles Bibliográficos
Autor principal: Ferenci, Tamás
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10585880/
https://www.ncbi.nlm.nih.gov/pubmed/37853374
http://dx.doi.org/10.1186/s12874-023-02061-w
_version_ 1785123041446985728
author Ferenci, Tamás
author_facet Ferenci, Tamás
author_sort Ferenci, Tamás
collection PubMed
description BACKGROUND: The World Health Organization (WHO)’s excess mortality estimates presented in May 2022 stirred controversy, due in part to the high estimate provided for Germany, which was later attributed to the spline model used. This paper aims to reproduce the problem using synthetic datasets, thus allowing the investigation of its sensitivity to parameters, both of the mortality curve and of the used method, thereby shedding light on the conditions that gave rise to this error and identifying possible remedies. METHODS: A negative binomial model was used accounting for long-term change, seasonality, flu seasons, and heat waves. Simulated mortality curves from this model were then analysed using simple methods (mean, linear trend), the WHO method, and the method of Acosta and Irizarry. RESULTS: The performance of the WHO’s method with its original parametrization was indeed very poor, however it can be profoundly improved by a better choice of parameters. The Acosta–Irizarry method outperformed the WHO method despite being also based on splines, but it was also dependent on its parameters. Linear extrapolation could produce very good results, but was highly dependent on the choice of the starting year, while the average was the worst in almost all cases. CONCLUSIONS: Splines are not inherently unsuitable for predicting baseline mortality, but caution should be taken. In particular, the results suggest that the key issue is that the splines should not be too flexible to avoid overfitting. Even after having investigated a limited number of scenarios, the results suggest that there is not a single method that outperforms the others in all situations. As the WHO method on the German data illustrates, whatever method is chosen, it remains important to visualize the data, the fit, and the predictions before trusting any result. It will be interesting to see whether further research including other scenarios will come to similar conclusions. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12874-023-02061-w.
format Online
Article
Text
id pubmed-10585880
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-105858802023-10-20 Comparing methods to predict baseline mortality for excess mortality calculations Ferenci, Tamás BMC Med Res Methodol Research BACKGROUND: The World Health Organization (WHO)’s excess mortality estimates presented in May 2022 stirred controversy, due in part to the high estimate provided for Germany, which was later attributed to the spline model used. This paper aims to reproduce the problem using synthetic datasets, thus allowing the investigation of its sensitivity to parameters, both of the mortality curve and of the used method, thereby shedding light on the conditions that gave rise to this error and identifying possible remedies. METHODS: A negative binomial model was used accounting for long-term change, seasonality, flu seasons, and heat waves. Simulated mortality curves from this model were then analysed using simple methods (mean, linear trend), the WHO method, and the method of Acosta and Irizarry. RESULTS: The performance of the WHO’s method with its original parametrization was indeed very poor, however it can be profoundly improved by a better choice of parameters. The Acosta–Irizarry method outperformed the WHO method despite being also based on splines, but it was also dependent on its parameters. Linear extrapolation could produce very good results, but was highly dependent on the choice of the starting year, while the average was the worst in almost all cases. CONCLUSIONS: Splines are not inherently unsuitable for predicting baseline mortality, but caution should be taken. In particular, the results suggest that the key issue is that the splines should not be too flexible to avoid overfitting. Even after having investigated a limited number of scenarios, the results suggest that there is not a single method that outperforms the others in all situations. As the WHO method on the German data illustrates, whatever method is chosen, it remains important to visualize the data, the fit, and the predictions before trusting any result. It will be interesting to see whether further research including other scenarios will come to similar conclusions. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12874-023-02061-w. BioMed Central 2023-10-18 /pmc/articles/PMC10585880/ /pubmed/37853374 http://dx.doi.org/10.1186/s12874-023-02061-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Ferenci, Tamás
Comparing methods to predict baseline mortality for excess mortality calculations
title Comparing methods to predict baseline mortality for excess mortality calculations
title_full Comparing methods to predict baseline mortality for excess mortality calculations
title_fullStr Comparing methods to predict baseline mortality for excess mortality calculations
title_full_unstemmed Comparing methods to predict baseline mortality for excess mortality calculations
title_short Comparing methods to predict baseline mortality for excess mortality calculations
title_sort comparing methods to predict baseline mortality for excess mortality calculations
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10585880/
https://www.ncbi.nlm.nih.gov/pubmed/37853374
http://dx.doi.org/10.1186/s12874-023-02061-w
work_keys_str_mv AT ferencitamas comparingmethodstopredictbaselinemortalityforexcessmortalitycalculations